SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

SAN

79.05

-1.48%↓

UCB

236.2

-0.51%↓

SHL.DE

35.53

+0.31%↑

ARGX

663.2

-0.51%↓

VIE

35.76

+0.48%↑

Search

Imerys SA.

Atidarymo kaina

SektoriusSveikatos priežiūra

22.12 0.82

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

21.88

Max

22.18

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-550M

-479M

Pardavimai

-130M

1.6B

P/E

Sektoriaus vid.

13.076

60.328

Pelnas, tenkantis vienai akcijai

-5.667

Dividendų pajamingumas

3.28

Pelno marža

-29.457

Darbuotojai

14,878

EBITDA

-310M

-43M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+17.14% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.28%

2.24%

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-295M

1.9B

Ankstesnė atidarymo kaina

21.3

Ankstesnė uždarymo kaina

22.12

Naujienos nuotaikos

By Acuity

58%

42%

305 / 348 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Imerys SA. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-26 21:14; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

2026-04-26 21:14; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Major Central Bank -2-

2026-04-24 19:19; UTC

Įsigijimai, susijungimai, perėmimai

Intertek Group Rejects EQT's Revised Offer

2026-04-26 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise After U.S. Tech Gains -- Market Talk

2026-04-26 23:44; UTC

Uždarbis

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

2026-04-26 23:44; UTC

Uždarbis

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

2026-04-26 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Falls Amid Dollar's Strength -- Market Talk

2026-04-26 23:33; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

2026-04-26 05:12; UTC

Uždarbis

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

2026-04-26 05:12; UTC

Uždarbis

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

2026-04-26 05:12; UTC

Uždarbis

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

2026-04-26 05:12; UTC

Uždarbis

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

2026-04-24 23:37; UTC

Įsigijimai, susijungimai, perėmimai

Scoring the Cook Era -- Barrons.com

2026-04-24 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026-04-24 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Financial Services Roundup: Market Talk

2026-04-24 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-04-24 20:39; UTC

Įsigijimai, susijungimai, perėmimai

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026-04-24 20:09; UTC

Uždarbis

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

2026-04-24 19:48; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

2026-04-24 19:25; UTC

Įsigijimai, susijungimai, perėmimai

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

2026-04-24 19:25; UTC

Įsigijimai, susijungimai, perėmimai

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

2026-04-24 19:22; UTC

Uždarbis

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

2026-04-24 19:06; UTC

Uždarbis

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

2026-04-24 19:05; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

2026-04-24 18:30; UTC

Įsigijimai, susijungimai, perėmimai

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

2026-04-24 18:28; UTC

Įsigijimai, susijungimai, perėmimai

Intertek Rejects Revised EQT Offer

2026-04-24 18:12; UTC

Rinkos pokalbiai

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

2026-04-24 18:06; UTC

Rinkos pokalbiai

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

2026-04-24 17:42; UTC

Uždarbis

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

2026-04-24 17:28; UTC

Uždarbis

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Imerys SA. Prognozė

Kainos tikslas

By TipRanks

17.14% į viršų

12 mėnesių prognozė

Vidutinis 25.7 EUR  17.14%

Aukščiausias 28.4 EUR

Žemiausias 23 EUR

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Imerys SA. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

1

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

29.06 / 30.24Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

305 / 348 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Imerys SA.

Imerys S.A. provides mineral-based specialty solutions for various industries worldwide. The company provides additives for paints, coatings, adhesives, caulks, sealants, and rubber; minerals for technical ceramics and traditional ceramics; functional additives for plastics and thermoset; high-performance binders for dry mix mortars and floor screeds; fillers and coatings for paper, board, and packaging applications; filtration agents for liquids and blood plasma; pharmaceutical diluents, coloring agents, processing aids, glidants, and lubricants for tablet production; engineered minerals for cosmetic industry; food additives to preserve flavor; coating agents to improve fertilizer fow; mineral-based cat litters; alumina for high-performance abrasives and graphite in brake pads; and carbon black for conductivity in onboard data systems. The company also offers minerals used to produce high purity silicon metal for electronics and solar panels; graphite and carbon-based solutions for industrial applications; mineral solutions for batteries and energy storage; refractory minerals and solutions for high-temperature processes; and alumina and zirconia for abrasives. It serves construction and infrastructure, consumer and health care, automotive and transportation, energy and electronics, and industry and equipment industries. The company was incorporated in 1880 and is headquartered in Paris, France. The company is a subsidiary of Belgian Securities BV.
help-icon Live chat